Thyroid Functional and Molecular Imaging.

[1]  A. Avram,et al.  Molecular Imaging for Thyrotoxicosis and Thyroid Nodules. , 2021, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  L. Giovanella,et al.  Thyroid dysfunctions induced by molecular cancer therapies: a synopsis for nuclear medicine thyroidologists , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  Xipeng Qiu,et al.  Updated Review of Nuclear Molecular Imaging of Thyroid Cancers. , 2021, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[4]  E. Hindié,et al.  The EANM practice guidelines for parathyroid imaging , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  D. Huglo,et al.  Quantitative dual isotope 123iodine/99mTc-MIBI scintigraphy: a new approach to rule out malignancy in thyroid nodules. , 2021, Annales d'endocrinologie.

[6]  J. Clerc.  Radioiodine Therapy (RIT) of thyroid autonomy. , 2021, The Quarterly Journal of Nuclear Medicine and Molecular Imaging.

[7]  J. Clerc.  Quantification of the Thyroid Scan (TS) and correlation to Multiparametric Ultrasounds (MPUS): A textbook case of nuclear molecular imaging , 2020 .

[8]  J. Clerc.  Quantified 123I-Thyroid Scan based classification of hyperthyroidism , 2020 .

[9]  M. Lozano,et al.  Evaluation of the role of thyroid scintigraphy in the differential diagnosis of thyrotoxicosis , 2020, Clinical endocrinology.

[10]  L. Cascione,et al.  Radiomics analysis of [18F] fluorodeoxyglucose-avid thyroid incidentalomas improves risk stratification and selection for clinical assessment. , 2020, Thyroid : official journal of the American Thyroid Association.

[11]  P. Trimboli,et al.  Performance of EU-TIRADS in malignancy risk stratification of thyroid nodules. A meta-analysis. , 2020, European journal of endocrinology.

[12]  P. Trimboli,et al.  Ultrasound systems for risk stratification of thyroid nodules prompt inappropriate biopsy in autonomously functioning thyroid nodules , 2020, Clinical endocrinology.

[13]  M. Luster,et al.  New! F-18-based PET/CT for sodium-iodine-symporter-targeted imaging! , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  Katsuhiko Kato,et al.  Investigation of post-therapeutic image-based thyroid dosimetry using quantitative SPECT/CT, iodine biokinetics, and the MIRD’s voxel S values in Graves’ disease , 2020, EJNMMI Physics.

[15]  M. Lassmann,et al.  Will SPECT/CT Cameras Soon Be Able to Display Absorbed Doses? Dosimetry from Single-Activity-Concentration Measurements , 2020, The Journal of Nuclear Medicine.

[16]  P. Trimboli,et al.  Can ultrasound systems for risk stratification of thyroid nodules identify follicular carcinoma? , 2020, Cancer cytopathology.

[17]  P. Trimboli,et al.  Diagnostic testing for Graves' or non‐Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography , 2019, Clinical endocrinology.

[18]  M. Luster,et al.  EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[19]  M. Plebani,et al.  Reflex TSH strategy: the good, the bad and the ugly , 2019, Clinical chemistry and laboratory medicine.

[20]  A. Zwanenburg.  Radiomics in nuclear medicine: robustness, reproducibility, standardization, and how to avoid data analysis traps and replication crisis , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  M. Dentice,et al.  Deiodinases and their intricate role in thyroid hormone homeostasis , 2019, Nature Reviews Endocrinology.

[22]  P. Arvan,et al.  The role of thyroglobulin in thyroid hormonogenesis , 2019, Nature Reviews Endocrinology.

[23]  L. Hegedüs,et al.  Duration of Hyperthyroidism and Lack of Sufficient Treatment Are Associated with Increased Cardiovascular Risk. , 2019, Thyroid : official journal of the American Thyroid Association.

[24]  P. Trimboli,et al.  PET/CT in thyroid nodule and differentiated thyroid cancer patients. The evidence-based state of the art , 2019, Reviews in Endocrine and Metabolic Disorders.

[25]  Xiu-zhi Guo,et al.  Data mining: Seasonal and temperature fluctuations in thyroid-stimulating hormone. , 2018, Clinical biochemistry.

[26]  R. Görges,et al.  Risk Stratification of Thyroid Nodules Using the Thyroid Imaging Reporting and Data System (TIRADS): The Omission of Thyroid Scintigraphy Increases the Rate of Falsely Suspected Lesions , 2018, The Journal of Nuclear Medicine.

[27]  T. DeGrado,et al.  [18F]Tetrafluoroborate ([18F]TFB) and its analogs for PET imaging of the sodium/iodide symporter , 2018, Theranostics.

[28]  Shangtong Lei.  Interpretation for surgical section of 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis , 2018 .

[29]  J. Hamming,et al.  Diagnostic Utility of Molecular and Imaging Biomarkers in Cytological Indeterminate Thyroid Nodules , 2018, Endocrine reviews.

[30]  M. Nikiforova,et al.  Update on Molecular Testing for Cytologically Indeterminate Thyroid Nodules. , 2018, Archives of pathology & laboratory medicine.

[31]  E. Cibas,et al.  The 2017 Bethesda System for Reporting Thyroid Cytopathology. , 2017, Journal of the American Society of Cytopathology.

[32]  Nicholas R. Schmit,et al.  Safety, pharmacokinetics, metabolism and radiation dosimetry of 18F-tetrafluoroborate (18F-TFB) in healthy human subjects , 2017, EJNMMI Research.

[33]  P. Trimboli,et al.  Searching for the most effective thyrotropin (TSH) threshold to rule-out autonomously functioning thyroid nodules in iodine deficient regions , 2016, Endocrine.

[34]  L. Braverman,et al.  Hyperthyroidism , 2016, The Lancet.

[35]  C. C. Pazos-Moura,et al.  Hypothalamus-Pituitary-Thyroid Axis. , 2016, Comprehensive Physiology.

[36]  Paolo Vitti,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[37]  F. Paparo,et al.  Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology. , 2016, European journal of endocrinology.

[38]  P. Trimboli,et al.  BRAF‐mutated carcinomas among thyroid nodules with prior indeterminate FNA report: a systematic review and meta‐analysis , 2016, Clinical endocrinology.

[39]  B. Krause,et al.  Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[40]  P. Trimboli,et al.  Molecular imaging with 99mTc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  Johannes W. Dietrich,et al.  Homeostatic Control of the Thyroid–Pituitary Axis: Perspectives for Diagnosis and Treatment , 2015, Front. Endocrinol..

[42]  P. Kopp,et al.  Pendrin and anoctamin as mediators of apical iodide efflux in thyroid cells , 2015, Current opinion in endocrinology, diabetes, and obesity.

[43]  M. Lichtenstein,et al.  Quantitative assessment of thyroid-to-background ratio improves the interobserver reliability of technetium-99m sestamibi thyroid scintigraphy for investigation of amiodarone-induced thyrotoxicosis , 2015, Nuclear medicine communications.

[44]  M. Zimmermann,et al.  Iodine deficiency and thyroid disorders. , 2015, The lancet. Diabetes & endocrinology.

[45]  L. Hegedüs,et al.  Duration of Thyroid Dysfunction Correlates with All-Cause Mortality. The OPENTHYRO Register Cohort , 2014, PloS one.

[46]  L. Ceriani,et al.  Role of isotope scan, including positron emission tomography/computed tomography, in nodular goitre. , 2014, Best practice & research. Clinical endocrinology & metabolism.

[47]  B. Corvilain,et al.  TSH measurement is not an appropriate screening test for autonomous functioning thyroid nodules: a retrospective study of 368 patients. , 2014, European journal of endocrinology.

[48]  J. Kwak,et al.  Thyroid Ultrasonography: Pitfalls and Techniques , 2014, Korean journal of radiology.

[49]  J. Clerc.  Imaging the thyroid in children. , 2014, Best practice & research. Clinical endocrinology & metabolism.

[50]  J. Faix.  Principles and pitfalls of free hormone measurements. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[51]  B. Velkeniers,et al.  Determination of free thyroid hormones. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[52]  L. Ceriani,et al.  Cellular and molecular basis for thyroid cancer imaging in nuclear medicine , 2013, Clinical and Translational Imaging.

[53]  A. Grüters,et al.  Novel insights on thyroid-stimulating hormone receptor signal transduction. , 2013, Endocrine reviews.

[54]  L. Ceriani,et al.  Diagnostic performance of 99mTc-MIBI scan in predicting the malignancy of thyroid nodules: a meta-analysis , 2013, Endocrine.

[55]  E. Vittinghoff,et al.  Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events: An Individual Participant Data Analysis From 6 Prospective Cohorts , 2012, Circulation.

[56]  Darya Chudova,et al.  Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. , 2012, The New England journal of medicine.

[57]  F. Fathinul,et al.  18[F]FDG-PET/CT is a Useful Molecular Marker in Evaluating Tumour Aggressiveness: A Revised Understanding of an In-Vivo FDG-PET Imaging that Alludes the Alteration of Cancer Biology , 2012, Cell Biochemistry and Biophysics.

[58]  A. Bockisch,et al.  Glucose Transporter 1 Expression, Tumor Proliferation, and Iodine/Glucose Uptake in Thyroid Cancer With Emphasis on Poorly Differentiated Thyroid Carcinoma , 2012, Clinical nuclear medicine.

[59]  J. Nortier,et al.  New treatment modalities in advanced thyroid cancer. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[60]  M. Vanderpump,et al.  The epidemiology of thyroid disease. , 2011, British medical bulletin.

[61]  C. Nies,et al.  German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease , 2011, Langenbeck's Archives of Surgery.

[62]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[63]  M. Lohse,et al.  Persistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors , 2009, PLoS biology.

[64]  E. Horvath,et al.  An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. , 2009, The Journal of clinical endocrinology and metabolism.

[65]  J. Clerc.  Scintigraphie thyroïdienne quantifiée (123I) du nodule thyroïdien : une nouvelle imagerie moléculaire , 2009 .

[66]  M. Piga,et al.  The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. , 2008, European journal of endocrinology.

[67]  B. Velkeniers,et al.  Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. , 2008, European journal of endocrinology.

[68]  D. Eterović,et al.  Thyroid echogenicity predicts outcome of radioiodine therapy in patients with Graves' disease. , 2007, The Journal of clinical endocrinology and metabolism.

[69]  A. Maclennan,et al.  Combined ultrasound and isotope scanning is more informative in the diagnosis of congenital hypothyroidism than single scanning , 2006, Archives of Disease in Childhood.

[70]  Yuji Nakamoto,et al.  Normal FDG distribution patterns in the head and neck: PET/CT evaluation. , 2005, Radiology.

[71]  W. Burchert,et al.  Scintigraphy for risk stratification of iodine-induced thyrotoxicosis in patients receiving contrast agent for coronary angiography: a prospective study of patients with low thyrotropin. , 2004, The Journal of clinical endocrinology and metabolism.

[72]  L. Hegedüs,et al.  The Thyroid Nodule , 2004 .

[73]  J. Morris,et al.  The sodium-iodide symporter. , 2004, Current drug targets. Immune, endocrine and metabolic disorders.

[74]  S. Larson,et al.  Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[75]  A. Burger.  Environment and thyroid function. , 2004, The Journal of clinical endocrinology and metabolism.

[76]  C. Ginter,et al.  The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. , 2003, Endocrine reviews.

[77]  J. Meller,et al.  The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[78]  H. Palmedo,et al.  Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[79]  A. Fusco,et al.  Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. , 2001, Endocrine reviews.

[80]  M. Hüfner,et al.  Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay. , 2000, Thyroid : official journal of the American Thyroid Association.

[81]  Y. Chou,et al.  Comparison of radioisotopic and ultrasonic scanning in the evaluation of neonatal hypothyroidism. , 1995, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

[82]  M. Maisey,et al.  Interindividual differences in the pituitary‐thyroid axis influence the interpretation of thyroid function tests , 1993, Clinical endocrinology.

[83]  A. Nonomura,et al.  Chronic thyroiditis: thyroid function and histologic correlations in 601 cases. , 1992, Human pathology.

[84]  H. Griffiths,et al.  Radiation Dose to Patients from Radiopharmaceuticals. ICRP Publication 53 , 1988 .

[85]  Larsen Pr.  Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones. , 1982 .

[86]  W. R. Burke,et al.  Effect of lithium on thyroid function. , 1971, The Journal of clinical endocrinology and metabolism.

[87]  Terry J. Smith,et al.  Graves' Disease. , 2016, The New England journal of medicine.

[88]  L. Ceriani,et al.  Focal thyroid incidental uptake detected by 18F-fluorodeoxyglucose positron emission tomography , 2013, Nuklearmedizin.

[89]  I. D. Thomas,et al.  Hyperthyroidism: Diagnosis and Treatment , 2012, Drugs.

[90]  A. Pinchera,et al.  Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal. , 2010, The Journal of clinical endocrinology and metabolism.

[91]  W. Eschner,et al.  Procedure guideline for thyroid scintigraphy (version 3) , 2007, Nuklearmedizin.

[92]  B. Biondi,et al.  Subclinical hyperthyroidism: clinical features and treatment options. , 2005, European journal of endocrinology.

[93]  S. Mattsson,et al.  Effective dose from radiopharmaceuticals , 2004, European Journal of Nuclear Medicine.

[94]  C. Schümichen,et al.  Ergebnisse der TcTUs-optimierten Radioiodtherapie bei multifokaler und disseminierter Autonomie , 1999, Nuklearmedizin.